Literature DB >> 12737867

Antibody to Haemophilus influenzae type b after routine and catch-up vaccination.

C L Trotter1, J McVernon, N J Andrews, M Burrage, M E Ramsay.   

Abstract

Since 1999, the number of cases of Haemophilus influenzae type b (Hib) disease in the UK has risen. We investigated the role of population immunity in this change by testing more than 2600 serum samples from children aged 1-15 years. After the introduction of the routine Hib conjugate vaccination programme for infants, median antibody titres rose significantly in 1-year-olds. Individuals who received their first dose of vaccine at age 1-4 years in the original catch-up campaign initially had much higher concentrations of antibody than those who had been immunised in infancy. A second catch-up campaign in children aged 6 months to 4 years should be highly effective in boosting immunity and reducing disease in the short term.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737867     DOI: 10.1016/s0140-6736(03)13172-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction.

Authors:  David A Ishola; Ray Borrow; Helen Findlow; Jamie Findlow; Caroline Trotter; Mary E Ramsay
Journal:  Clin Vaccine Immunol       Date:  2012-05-30

2.  Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom.

Authors:  J McVernon; M E Ramsay; A R McLean
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

3.  Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.

Authors:  Caroline L Trotter; Ray Borrow; Jamie Findlow; Ann Holland; Sarah Frankland; Nick J Andrews; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

4.  Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem (®) demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine.

Authors:  Sanet Aspinall; Deirdre Traynor; Philip Bedford; Katharina Hartmann
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

5.  Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands.

Authors:  Leo M Schouls; Arie van der Ende; Ingrid van de Pol; Corrie Schot; Lodewijk Spanjaard; Paul Vauterin; Dorus Wilderbeek; Sandra Witteveen
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Detection of Haemophilus influenzae type b by real-time PCR.

Authors:  Adrian Marty; Oliver Greiner; Philip J R Day; Sibylle Gunziger; Kathrin Mühlemann; David Nadal
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

7.  Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.

Authors:  Dominic F Kelly; E Richard Moxon; Ly-Mee Yu; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2008-09-10

Review 8.  Haemophilus influenzae type b conjugate vaccines.

Authors:  Dominic F Kelly; E Richard Moxon; Andrew J Pollard
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

9.  Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study.

Authors:  Jodie McVernon; Caroline L Trotter; Mary P E Slack; Mary E Ramsay
Journal:  BMJ       Date:  2004-09-18

10.  Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.

Authors:  Paul Balmer; Ray Borrow; Jamie Findlow; Rosalind Warrington; Sarah Frankland; Pauline Waight; Robert George; Nick Andrews; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2007-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.